Human mesenchymal stem cell secretomes: Factors affecting profiling and challenges in clinical application
The promising field of regenerative medicine is thrilling as it can repair and restore organs for various debilitating diseases. Mesenchymal stem cells are one of the main components in regenerative medicine that work through the release of secretomes. By adopting the use of the secretome in cell-fr...
Gespeichert in:
| Veröffentlicht in: | Cell and tissue research 2024-03, Vol.395 (3), p.227-250 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 250 |
|---|---|
| container_issue | 3 |
| container_start_page | 227 |
| container_title | Cell and tissue research |
| container_volume | 395 |
| creator | Noor Azlan, Noor Anastasha Balqis Vitus, Vieralynda Nor Rashid, Nurshamimi Nordin, Fazlina Tye, Gee Jun Wan Kamarul Zaman, Wan Safwani |
| description | The promising field of regenerative medicine is thrilling as it can repair and restore organs for various debilitating diseases. Mesenchymal stem cells are one of the main components in regenerative medicine that work through the release of secretomes. By adopting the use of the secretome in cell-free-based therapy, we may be able to address the challenges faced in cell-based therapy. As one of the components of cell-free-based therapy, secretome has the advantage of a better safety and efficacy profile than mesenchymal stem cells. However, secretome has its challenges that need to be addressed, such as its bioprocessing methods that may impact the secretome content and its mechanisms of action in clinical settings. Effective and standardization of bioprocessing protocols are important to ensure the supply and sustainability of secretomes for clinical applications. This may eventually impact its commercialization and marketability. In this review, the bioprocessing methods and their impacts on the secretome profile and treatment are discussed. This improves understanding of its fundamental aspects leading to potential clinical applications. |
| doi_str_mv | 10.1007/s00441-023-03857-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2929057521</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2929057521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-2a4b35ded164e2cf2e56fc08959f73ded6b24ff04919d65a7381dfbf45a2a1353</originalsourceid><addsrcrecordid>eNp9kU1v2zAMhoViRZN-_IEdBgG79OKV-rS121Csy4ACvbRAb4IiU4kDW84k-9B_P6XpVmCHnUSQD19SfAn5yOALA6hvMoCUrAIuKhCNqit5QpZMCl5BUzcfyBIE8KrW-nlBznPeATCptTkjC9FwKUHwJdmt5sFFOmDG6Lcvg-tpnnCgHvsSoU84jaX4ld45P40pUxcC-qmLG7pPY-j6Q-RiS_3W9T3GDWbaRepLvvNFzO33fQmmboyX5DS4PuPV23tBnu6-P96uqvuHHz9vv91XXtRqqriTa6FabJmWyH3gqHTw0BhlQi1KXq-5DAGkYabVytWiYW1YB6kcd0wocUGuj7plwV8z5skOXT78x0Uc52y54QZUrTgr6Od_0N04p1i2K5QQkhltdKH4kfJpzDlhsPvUDS69WAb24IQ9OmGLE_bVCStL06c36Xk9YPu35c_pCyCOQC6lcrf0Pvs_sr8BqMWU3A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2933419696</pqid></control><display><type>article</type><title>Human mesenchymal stem cell secretomes: Factors affecting profiling and challenges in clinical application</title><source>SpringerNature Journals</source><creator>Noor Azlan, Noor Anastasha Balqis ; Vitus, Vieralynda ; Nor Rashid, Nurshamimi ; Nordin, Fazlina ; Tye, Gee Jun ; Wan Kamarul Zaman, Wan Safwani</creator><creatorcontrib>Noor Azlan, Noor Anastasha Balqis ; Vitus, Vieralynda ; Nor Rashid, Nurshamimi ; Nordin, Fazlina ; Tye, Gee Jun ; Wan Kamarul Zaman, Wan Safwani</creatorcontrib><description>The promising field of regenerative medicine is thrilling as it can repair and restore organs for various debilitating diseases. Mesenchymal stem cells are one of the main components in regenerative medicine that work through the release of secretomes. By adopting the use of the secretome in cell-free-based therapy, we may be able to address the challenges faced in cell-based therapy. As one of the components of cell-free-based therapy, secretome has the advantage of a better safety and efficacy profile than mesenchymal stem cells. However, secretome has its challenges that need to be addressed, such as its bioprocessing methods that may impact the secretome content and its mechanisms of action in clinical settings. Effective and standardization of bioprocessing protocols are important to ensure the supply and sustainability of secretomes for clinical applications. This may eventually impact its commercialization and marketability. In this review, the bioprocessing methods and their impacts on the secretome profile and treatment are discussed. This improves understanding of its fundamental aspects leading to potential clinical applications.</description><identifier>ISSN: 0302-766X</identifier><identifier>EISSN: 1432-0878</identifier><identifier>DOI: 10.1007/s00441-023-03857-4</identifier><identifier>PMID: 38244032</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Human Genetics ; Mesenchymal stem cells ; Molecular Medicine ; Proteomics ; Regenerative medicine ; Review ; Secretome ; Standardization ; Stem cells ; Therapeutic applications</subject><ispartof>Cell and tissue research, 2024-03, Vol.395 (3), p.227-250</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-2a4b35ded164e2cf2e56fc08959f73ded6b24ff04919d65a7381dfbf45a2a1353</citedby><cites>FETCH-LOGICAL-c375t-2a4b35ded164e2cf2e56fc08959f73ded6b24ff04919d65a7381dfbf45a2a1353</cites><orcidid>0000-0002-8113-0370</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00441-023-03857-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00441-023-03857-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38244032$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Noor Azlan, Noor Anastasha Balqis</creatorcontrib><creatorcontrib>Vitus, Vieralynda</creatorcontrib><creatorcontrib>Nor Rashid, Nurshamimi</creatorcontrib><creatorcontrib>Nordin, Fazlina</creatorcontrib><creatorcontrib>Tye, Gee Jun</creatorcontrib><creatorcontrib>Wan Kamarul Zaman, Wan Safwani</creatorcontrib><title>Human mesenchymal stem cell secretomes: Factors affecting profiling and challenges in clinical application</title><title>Cell and tissue research</title><addtitle>Cell Tissue Res</addtitle><addtitle>Cell Tissue Res</addtitle><description>The promising field of regenerative medicine is thrilling as it can repair and restore organs for various debilitating diseases. Mesenchymal stem cells are one of the main components in regenerative medicine that work through the release of secretomes. By adopting the use of the secretome in cell-free-based therapy, we may be able to address the challenges faced in cell-based therapy. As one of the components of cell-free-based therapy, secretome has the advantage of a better safety and efficacy profile than mesenchymal stem cells. However, secretome has its challenges that need to be addressed, such as its bioprocessing methods that may impact the secretome content and its mechanisms of action in clinical settings. Effective and standardization of bioprocessing protocols are important to ensure the supply and sustainability of secretomes for clinical applications. This may eventually impact its commercialization and marketability. In this review, the bioprocessing methods and their impacts on the secretome profile and treatment are discussed. This improves understanding of its fundamental aspects leading to potential clinical applications.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Human Genetics</subject><subject>Mesenchymal stem cells</subject><subject>Molecular Medicine</subject><subject>Proteomics</subject><subject>Regenerative medicine</subject><subject>Review</subject><subject>Secretome</subject><subject>Standardization</subject><subject>Stem cells</subject><subject>Therapeutic applications</subject><issn>0302-766X</issn><issn>1432-0878</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kU1v2zAMhoViRZN-_IEdBgG79OKV-rS121Csy4ACvbRAb4IiU4kDW84k-9B_P6XpVmCHnUSQD19SfAn5yOALA6hvMoCUrAIuKhCNqit5QpZMCl5BUzcfyBIE8KrW-nlBznPeATCptTkjC9FwKUHwJdmt5sFFOmDG6Lcvg-tpnnCgHvsSoU84jaX4ld45P40pUxcC-qmLG7pPY-j6Q-RiS_3W9T3GDWbaRepLvvNFzO33fQmmboyX5DS4PuPV23tBnu6-P96uqvuHHz9vv91XXtRqqriTa6FabJmWyH3gqHTw0BhlQi1KXq-5DAGkYabVytWiYW1YB6kcd0wocUGuj7plwV8z5skOXT78x0Uc52y54QZUrTgr6Od_0N04p1i2K5QQkhltdKH4kfJpzDlhsPvUDS69WAb24IQ9OmGLE_bVCStL06c36Xk9YPu35c_pCyCOQC6lcrf0Pvs_sr8BqMWU3A</recordid><startdate>20240301</startdate><enddate>20240301</enddate><creator>Noor Azlan, Noor Anastasha Balqis</creator><creator>Vitus, Vieralynda</creator><creator>Nor Rashid, Nurshamimi</creator><creator>Nordin, Fazlina</creator><creator>Tye, Gee Jun</creator><creator>Wan Kamarul Zaman, Wan Safwani</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7SS</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8113-0370</orcidid></search><sort><creationdate>20240301</creationdate><title>Human mesenchymal stem cell secretomes: Factors affecting profiling and challenges in clinical application</title><author>Noor Azlan, Noor Anastasha Balqis ; Vitus, Vieralynda ; Nor Rashid, Nurshamimi ; Nordin, Fazlina ; Tye, Gee Jun ; Wan Kamarul Zaman, Wan Safwani</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-2a4b35ded164e2cf2e56fc08959f73ded6b24ff04919d65a7381dfbf45a2a1353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Human Genetics</topic><topic>Mesenchymal stem cells</topic><topic>Molecular Medicine</topic><topic>Proteomics</topic><topic>Regenerative medicine</topic><topic>Review</topic><topic>Secretome</topic><topic>Standardization</topic><topic>Stem cells</topic><topic>Therapeutic applications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Noor Azlan, Noor Anastasha Balqis</creatorcontrib><creatorcontrib>Vitus, Vieralynda</creatorcontrib><creatorcontrib>Nor Rashid, Nurshamimi</creatorcontrib><creatorcontrib>Nordin, Fazlina</creatorcontrib><creatorcontrib>Tye, Gee Jun</creatorcontrib><creatorcontrib>Wan Kamarul Zaman, Wan Safwani</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cell and tissue research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Noor Azlan, Noor Anastasha Balqis</au><au>Vitus, Vieralynda</au><au>Nor Rashid, Nurshamimi</au><au>Nordin, Fazlina</au><au>Tye, Gee Jun</au><au>Wan Kamarul Zaman, Wan Safwani</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human mesenchymal stem cell secretomes: Factors affecting profiling and challenges in clinical application</atitle><jtitle>Cell and tissue research</jtitle><stitle>Cell Tissue Res</stitle><addtitle>Cell Tissue Res</addtitle><date>2024-03-01</date><risdate>2024</risdate><volume>395</volume><issue>3</issue><spage>227</spage><epage>250</epage><pages>227-250</pages><issn>0302-766X</issn><eissn>1432-0878</eissn><abstract>The promising field of regenerative medicine is thrilling as it can repair and restore organs for various debilitating diseases. Mesenchymal stem cells are one of the main components in regenerative medicine that work through the release of secretomes. By adopting the use of the secretome in cell-free-based therapy, we may be able to address the challenges faced in cell-based therapy. As one of the components of cell-free-based therapy, secretome has the advantage of a better safety and efficacy profile than mesenchymal stem cells. However, secretome has its challenges that need to be addressed, such as its bioprocessing methods that may impact the secretome content and its mechanisms of action in clinical settings. Effective and standardization of bioprocessing protocols are important to ensure the supply and sustainability of secretomes for clinical applications. This may eventually impact its commercialization and marketability. In this review, the bioprocessing methods and their impacts on the secretome profile and treatment are discussed. This improves understanding of its fundamental aspects leading to potential clinical applications.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>38244032</pmid><doi>10.1007/s00441-023-03857-4</doi><tpages>24</tpages><orcidid>https://orcid.org/0000-0002-8113-0370</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0302-766X |
| ispartof | Cell and tissue research, 2024-03, Vol.395 (3), p.227-250 |
| issn | 0302-766X 1432-0878 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2929057521 |
| source | SpringerNature Journals |
| subjects | Biomedical and Life Sciences Biomedicine Human Genetics Mesenchymal stem cells Molecular Medicine Proteomics Regenerative medicine Review Secretome Standardization Stem cells Therapeutic applications |
| title | Human mesenchymal stem cell secretomes: Factors affecting profiling and challenges in clinical application |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T13%3A07%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20mesenchymal%20stem%20cell%20secretomes:%20Factors%20affecting%20profiling%20and%20challenges%20in%20clinical%20application&rft.jtitle=Cell%20and%20tissue%20research&rft.au=Noor%20Azlan,%20Noor%20Anastasha%20Balqis&rft.date=2024-03-01&rft.volume=395&rft.issue=3&rft.spage=227&rft.epage=250&rft.pages=227-250&rft.issn=0302-766X&rft.eissn=1432-0878&rft_id=info:doi/10.1007/s00441-023-03857-4&rft_dat=%3Cproquest_cross%3E2929057521%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2933419696&rft_id=info:pmid/38244032&rfr_iscdi=true |